Dr. Huff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1999 - 2001
- Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
- Baylor College of MedicineClass of 1992
Certifications & Licensure
- FL State Medical License 2021 - Present
- MD State Medical License 1995 - 2026
- VA State Medical License 2021 - 2026
- PA State Medical License 2020 - 2024
- NC State Medical License 2020 - 2022
- TX State Medical License 1994 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma Start of enrollment: 2017 Oct 25
Roles: Contact
Publications & Presentations
PubMed
- 1376 citationsHLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Paul O'Donnell, Heather J. Symons, Allen R. Chen, M. Susan Leffell
Biology of Blood and Marrow Transplantation. 2008-06-01 - 214 citationsNonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on OutcomeYvette L. Kasamon, Leo Luznik, Mary S. Leffell, Jeanne Kowalski, Hua Ling Tsai
Biology of Blood and Marrow Transplantation. 2010-04-01 - 152 citationsSingle-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDSChristopher G. Kanakry, Hua Ling Tsai, Javier Bolaños-Meade, B. Douglas Smith, Ivana Gojo
Blood. 2014-12-11
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/carol-huff
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: